Athena A Schepmoes
Overview
Explore the profile of Athena A Schepmoes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu J, Cao S, Imbach K, Gritsenko M, Lih T, Kyle J, et al.
Cancer Cell
. 2024 Jul;
42(7):1217-1238.e19.
PMID: 38981438
Although genomic anomalies in glioblastoma (GBM) have been well studied for over a decade, its 5-year survival rate remains lower than 5%. We seek to expand the molecular landscape of...
2.
Moradian A, Goonatilleke E, Lin T, Hatten-Beck M, Emrick M, Schepmoes A, et al.
Clin Chem
. 2024 Mar;
70(6):855-864.
PMID: 38549041
Background: The enhanced precision and selectivity of liquid chromatography-tandem mass spectrometry (LC-MS/MS) makes it an attractive alternative to certain clinical immunoassays. Easily transferrable work flows could help facilitate harmonization and...
3.
Zhang Y, Bharathi V, Dokoshi T, de Anda J, Ursery L, Kulkarni N, et al.
Proc Natl Acad Sci U S A
. 2024 Feb;
121(6):e2300644120.
PMID: 38306481
It is unclear how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leads to the strong but ineffective inflammatory response that characterizes severe Coronavirus disease 2019 (COVID-19), with amplified immune...
4.
Webb-Robertson B, Nakayasu E, Dong F, Waugh K, Flores J, Bramer L, et al.
iScience
. 2024 Feb;
27(2):108769.
PMID: 38303689
Type 1 diabetes (T1D) is a chronic condition caused by autoimmune destruction of the insulin-producing pancreatic β cells. While it is known that gene-environment interactions play a key role in...
5.
Rahman S, Chen S, Wang Y, Gao Y, Schepmoes A, Fillmore T, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760474
A major challenge in lung cancer prevention and cure hinges on identifying the at-risk population that ultimately develops lung cancer. Previously, we reported proteomic alterations in the cytologically normal bronchial...
6.
Schutzer S, Liu T, Tsai C, Petyuk V, Schepmoes A, Wang Y, et al.
Ann Med
. 2023 Sep;
55(1):2208372.
PMID: 37722890
Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and fibromyalgia have overlapping neurologic symptoms particularly disabling fatigue. This has given rise to the question whether they are distinct central nervous system (CNS)...
7.
Dou Y, Katsnelson L, Gritsenko M, Hu Y, Reva B, Hong R, et al.
Cancer Cell
. 2023 Aug;
41(9):1586-1605.e15.
PMID: 37567170
We characterized a prospective endometrial carcinoma (EC) cohort containing 138 tumors and 20 enriched normal tissues using 10 different omics platforms. Targeted quantitation of two peptides can predict antigen processing...
8.
Nakayasu E, Bramer L, Ansong C, Schepmoes A, Fillmore T, Gritsenko M, et al.
Cell Rep Med
. 2023 Jun;
4(7):101093.
PMID: 37390828
Type 1 diabetes (T1D) results from autoimmune destruction of β cells. Insufficient availability of biomarkers represents a significant gap in understanding the disease cause and progression. We conduct blinded, two-phase...
9.
Fritch E, Sanders W, Sims A, Herring L, Barker N, Schepmoes A, et al.
iScience
. 2023 May;
26(6):106780.
PMID: 37193127
Among all RNA viruses, coronavirus RNA transcription is the most complex and involves a process termed "discontinuous transcription" that results in the production of a set of 3'-nested, co-terminal genomic...
10.
Bramer L, Hontz R, Eisfeld A, Sims A, Kim Y, Stratton K, et al.
Heliyon
. 2023 Mar;
9(3):e13795.
PMID: 36915486
The detailed mechanisms of COVID-19 infection pathology remain poorly understood. To improve our understanding of SARS-CoV-2 pathology, we performed a multi-omics and correlative analysis of an immunologically naïve SARS-CoV-2 clinical...